Related Experiment Video
Updated: Nov 11, 2025
11:01
Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes
Published on: August 24, 2021
3.0K
Autophagy-Deficient Pancreatic Cancer Cells Depend on Macropinocytosis
Cancer Discovery
|March 27, 2021
Abstract:
Blocking autophagy in cancer cells triggered transcription factor NRF2 to induce macropinocytosis.
Insights
Blocking autophagy in cancer cells activates the NRF2 (nuclear factor erythroid 2-related factor 2) transcription factor. This activation then triggers macropinocytosis, a process where cells engulf large amounts of extracellular fluid.
Area of Science:
- Cell biology
- Cancer research
- Molecular mechanisms
Background:
- Autophagy is a cellular degradation process crucial for maintaining homeostasis.
- Dysregulation of autophagy is implicated in various diseases, including cancer.
- Transcription factor NRF2 plays a role in cellular defense and stress response.
Purpose of the Study:
- To investigate the downstream effects of autophagy inhibition in cancer cells.
- To elucidate the role of transcription factor NRF2 in response to autophagy blockade.
- To determine if NRF2 activation influences cellular uptake mechanisms like macropinocytosis.
Main Methods:
- Utilized cancer cell lines.
- Inhibited autophagy using pharmacological agents.
- Assessed NRF2 activation via Western blotting and reporter assays.
- Quantified macropinocytosis using fluorescently labeled dextran uptake.
Main Results:
- Autophagy inhibition led to a significant increase in NRF2 transcriptional activity.
- Activated NRF2 was found to directly upregulate genes involved in macropinocytosis.
- Cancer cells exhibited enhanced macropinocytosis upon autophagy blockade.
Conclusions:
- Inhibition of autophagy in cancer cells triggers a compensatory macropinocytosis pathway.
- NRF2 acts as a key mediator, linking autophagy suppression to the induction of macropinocytosis.
- Targeting this NRF2-mediated macropinocytosis could represent a novel therapeutic strategy in cancer treatment.
More Related Videos
Related Concept Videos
01:27Autophagy
5.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.2K
01:36Delivery Pathways to the Lysosome
8.4K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.4K
02:53Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
01:17Phagocytosis of Apoptotic Cells
4.2K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
4.2K
03:03mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K
01:18Autophagic Cell Death
3.7K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.7K